Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: BM&FBOVESPA
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Bristol-Myers Squibb Co

+ Add to Watchlist

BMYB34:BZ

210.800 BRL 9.600 4.77%

As of 12:44:54 ET on 05/20/2015.

Snapshot for Bristol-Myers Squibb Co (BMYB34)

Open: 210.800 Day's Range: 210.800 - 210.800 Volume: 400
Previous Close: 201.200 52wk Range: 111.230 - 223.430 1-Yr Rtn: -

Stock Chart for BMYB34

No chart data available.
  • BMYB34:BZ 210.800
  • 1D
  • 1M
  • 1Y
201.200
Interactive BMYB34 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BMYB34

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. IBOV -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M BRL) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume 37
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.09%
Cash Dividend (BRL) 0.7304
Dividend Ex-Date 04/01/2015
5 Year Dividend Growth -
Next Earnings Announcement 07/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BMYB34

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BMYB34

Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.

Lamberto AndreottiChairmanGiovanni CaforioChief Executive Officer
Louis S SchmuklerPres:Global Manufacturing & SupplyCharles A BancroftExec VP/CFO
More Company Profile & Key Executives for BMYB34

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil